One limitation of response assessment in glioma using conventional MRI is its reliance on the measurement of contrast enhancement reflecting a disrupted blood–brain barrier. This signal may be normalized by antiangiogenic therapy, known as pseudoresponse. Amino acid PET tracers offer a more sensitive method to identify viable glioma tissue.
|Title of host publication||Clinical Nuclear Medicine in Neurology : An Atlas of Challenging Cases|
|Editors||Andrea Varrone, Silvia Morbelli, Valentina Garibotto|
|Number of pages||3|
|Place of Publication||Cham|
|Publisher||Springer International Publishing|
|Publication status||Published - 2022|